Skip to main content
. 2008 Jun 18;82(17):8619–8628. doi: 10.1128/JVI.00027-08

FIG. 2.

FIG. 2.

Overview of ELISPOT responses to the 12 consecutive HIV-1 and HIV-2 Gag peptide pools. (A) HIV-1-infected patients. Top panel, homologous responses to HIV-1 Gag peptide pools; bottom panel, heterologous responses to HIV-2 Gag peptide pools. (B) HIV-2-infected patients. Top panel, homologous responses to HIV-2 Gag peptide pools; bottom panel, heterologous responses to HIV-1 Gag peptide pools. Shaded areas represent negative cutoff values for the HIV-1 and HIV-2 peptide pools, respectively, calculated as the average responses plus two times the standard deviation among 14 HIV-seronegative blood donors. Different line patterns and colors represent responses above the negative cutoff value for individual HIV-1-infected patients (A) and HIV-2-infected patients (B).